China Checks Hospitals For Alleged Sanofi Bribery; Pricing Probes Focus On European Pharma
This article was originally published in PharmAsia News
Executive Summary
Chinese authorities have requested health institutes to conduct investigations over suspected kickback payments to doctors by Sanofi, with a growing focus of the probes on European drug companies.